semaglutide fat vs muscle loss Semaglutides and Emsculpt NEO at Shape Med Centers How Semaglutide and Tirzepatide Affect

Semaglutide, the blockbuster GLP-1 receptor agonist marketed under names like Ozempic (type 2 diabetes) and Wegovy (weight loss), has rapidly become one of the most consequential drugs in modern healthcare

Patients taking the drug in a clinical trial saw significantly fewer heart attacks and strokes and these benefits were similar for people who were only marginally overweight and those who were the most obese

Also, more work would be needed to understand appropriate dosage and adverse effects before using the blockbuster drugs in new way, she said

Whilst mild to moderate gastrointestinal symptoms are expected with Ozempic therapy, certain presentations warrant prompt medical assessment to exclude serious complications or conditions requiring intervention